Titles and Publications

Key Dates

Oct. 4 at 9 a.m. EDT

Titles and Authors for Regular, Young Investigator Award (YIA) and Immune Engineering Abstracts will be posted on this page.

Oct. 30 at 9 a.m. EDT

Titles and Authors for Late-Breaking Abstracts - Clinical Only (LBA) will be posted on this page.

Nov. 5 at 8 a.m. EST

All abstracts will be published in the Journal for ImmunoTherapy of Cancer (JITC) Abstract Supplement. A link to the supplement will be posted on this page.

Abstract Embargo Information

Abstract Content Embargo (All Abstract Types)

Full Regular Abstract, Young Investigator Award (YIA), Immune Engineering Abstracts, and Late-breaking Abstract - Clinical Only (LBA) content will be embargoed until Nov. 5, 2024 at 9 a.m. ET. This includes content within the original abstract submitted, additional data that was available on a poster of the abstract and/or any updated and/or any new data that will be available in oral presentations in SITC’s Annual Meeting.

Poster Presentation Data Embargo

(Posters only): Any additional data that will be available on a poster that is beyond what was submitted in the abstract is embargoed until Nov. 7, 2024 at 9 a.m. CT. This embargo applies to poster-only presentations.

Oral Presentation Data Embargo

Any updated and/or new data that will be available in an oral presentation is embargoed until the date and time of the presentation. If the oral presenter is also creating a poster which includes updated and/or new data, the poster shares the same Oral Presentation Embargo date, not the poster embargo date specified above. This embargo applies to oral abstract presentations.